<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Allergan Sales LLC., et. al.; Withdrawal of Approval of 10 Abbreviated New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Allergan Sales LLC., et. al.; Withdrawal of Approval of 10 Abbreviated New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2023-02-02 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on November 21, 2022. The document announced the withdrawal of approval (as of December 21, 2022) of 10 abbreviated new drug applications (ANDAs) from multiple applicants. The document indicated that FDA was withdrawing approval of the following ANDAs after receiving withdrawal requests from Sunstar Americas, Inc., 301 East Central Rd., Schaumburg, IL 60195: ANDA 076434, Chlorhexidine Gluconate So...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-02155</p>
    <p><strong>Publication Date:</strong> 2023-02-02</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/02/02/2023-02155/allergan-sales-llc-et-al-withdrawal-of-approval-of-10-abbreviated-new-drug-applications-correction">https://www.federalregister.gov/documents/2023/02/02/2023-02155/allergan-sales-llc-et-al-withdrawal-of-approval-of-10-abbreviated-new-drug-applications-correction</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-02155</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
